Lv3
302 积分 2025-02-03 加入
EGFR‐TKIs Induced DPP4 Drives Metabolic Reprogramming of Persister Cells in Lung Cancer
1天前
待确认
GSTA1 Conferred Tolerance to Osimertinib and Provided Strategies to Overcome Drug-Tolerant Persister in EGFR-Mutant Lung Adenocarcinoma
1天前
已完结
TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma
1天前
求助中
CD105 blockade restores osimertinib sensitivity in drug-resistant EGFR-mutant non-small cell lung cancer
1天前
已完结
Targeting persister cells: proactively overcoming therapy resistance in aggressive B cell lymphomas
1天前
待确认
Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR -Mutant Lung Cancer
1天前
求助中
CD24 is a promising immunotherapeutic target for enhancing efficacy of third‐generation EGFR‐TKIs on EGFR‐mutated lung cancer
1天前
已完结
Clonal dynamics shaped by diverse drug-tolerant persister states in melanoma resistance
1天前
已关闭
Realigned transsulfuration drives BRAF-V600E-targeted therapy resistance in melanoma
1天前
已完结
Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and Patients
1天前
已完结
皖公网安备34019202002308
